CME: Investigator Interview: Volume Progression in ADPKD

Name: Investigator Interview: Volume Progression in ADPKD
Uploaded: 2021-09-21T04:00:00+00:00
Duration: 3 min 44 s
Description: In this video, Dr. Arlene Chapman, Professor of Medicine and Chief of Nephrology at the University of Chicago, talks about a 2006 New England Journal of Me

Media formats available:

Details

Presenters

Overview
In this video, Dr. Arlene Chapman, Professor of Medicine and Chief of Nephrology at the University of Chicago, talks about a 2006 New England Journal of Medicine paper she co-authored titled "Volume Progression in Polycystic Kidney Disease."
Publication Dates
Release Date: 09/21/2021

Arlene B. Chapman, MD

Guest

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Finerenone in HFpEF: Key Insights From ESC HF
Finerenone in HFpEF: Key Insights From ESC HF
Cardiology
Finerenone in HFpEF: Key Insights From ESC HF
John W. Ostrominski, MD, MPH
John W. Ostrominski, MD, MPH
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Cardiology
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Muthiah Vaduganathan, MD, MPH
Muthiah Vaduganathan, MD, MPH
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
CME/CE
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP; Ankana Daga, MD
0.25 credits
Richard Lafayette, MD, FACP; Ankana Daga, MD
0.25 credits
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
CME/CE
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits
Antoine Lanot, MD, PhD; Gil Yosipovitch, MD
0.25 credits

Investigator Interview: Volume Progression in ADPKD

Overview

Publication Dates

Recommended

Title